Urate Transporters: An Evolving Field

Seminars in Nephrology

Volumn 31, Issue 5, 2011, Pages 400-409

  Anzai, Naohiko ^a   Endou, Hitoshi ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diuretics; Genome wide association study; Gout; Hyperuricemia; Hypouricemia

Indexed keywords

4 AMINOHIPPURIC ACID; 6 HYDROXYBENZBROMARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; ANTIPORTER; BENZBROMARONE; BREAST CANCER RESISTANCE PROTEIN; GLUCOSE TRANSPORTER; HYDROCHLOROTHIAZIDE; LOSARTAN; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 4; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 10; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; PROTEIN GLUT9; PROTEIN SLC2A9; PYRAZINOIC ACID; SODIUM DEPENDENT PHOSPHATE TRANSPORTER 4; SODIUM PHOSPHATE COTRANSPORTER; SODIUM PHOSPHATE COTRANSPORTER 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; URATE; URATE TRANSPORTER; URATE TRANSPORTER URAT1; URICOSURIC AGENT; VOLTAGE DRIVEN URATE TRANSPORTER URATV1;

ANION EXCHANGE; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPERURICEMIA; INTESTINE SECRETION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIVER METABOLISM; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SECRETION; SLC2A9 GENE; URATE SECRETION; URATE TRANSPORT; URIC ACID BLOOD LEVEL;

ABSORPTION; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INTESTINES; KIDNEY; LIVER; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; URIC ACID;

EID: 80054082834     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.08.003     Document Type: Article

References (60)

1. Sica D.A., Schoolwerth A.C. Renal handling of organic anions and cations: excretion of uric acid. The kidney 2000, 680-700. WB Saunders, Philadelphia. 6th ed. B.M. Brenner (Ed.).
2. Anzai N., Endou H. Drug discovery for hyperuricemia. Expert Opin Drug Discov 2007, 2:1251-1261.
3. Anzai N., Kanai Y., Endou H. New insights into renal transport of urate. Curr Opin Rheumatol 2007, 19:151-157.
4. Burckhardt G., Pritchard J.B. Organic anion and cation antiporters. The kidney physiology and pathophysiology 2000, 193-222. Lippincott Williams & Wilkins, Philadelphia. 3rd ed. D.W. Seldin, G. Giebisch (Eds.).
5. Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S.H., et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417:447-452.
6. Anzai N., Kanai Y., Endou H. Organic anion transporter family: current knowledge. J Pharmacol Sci 2006, 100:411-426.
7. Jutabha P., Kanai Y., Hosoyamada H., Chairoungdua A., Kim D.K., Iribe Y., et al. Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem 2003, 278:27930-27938.
8. van Aubel R.A., Smeets P.H., van den Heuvel J.J., Russel F.G. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 2005, 288:F327-F333.
9. Anzai N., Miyazaki H., Noshiro R., Khamdang S., Chairoungdua A., Shin H.J., et al. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem 2004, 279:45942-45950.
10. Vitart V., Rudan I., Hayward C., Gray N.K., Floyd J., Palmer C.N., et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008, 40:437-442.
11. Caulfield M.J., Munroe P.B., O'Neill D., Witkowska K., Charchar F.J., Doblado M., et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008, 5:e197.
12. Li S., Sanna S., Maschio A., Busonero F., Usala G., Mulas A., et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007, 3:e194.
13. Wallace C., Newhouse S.J., Braund P., Zhang F., Tobin M., Falchi M., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-149.
14. Döring A., Gieger C., Mehta D., Gohlke H., Prokisch H., Coassin S., et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008, 40:430-436.
15. Dehghan A., Köttgen A., Yang Q., Hwang S.J., Kao W.L., Rivadeneira F., et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008, 372:1953-1961.
16. Kolz M., Johnson T., Sanna S., Teumer A., Vitart V., Perola M., et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. Plos Genet 2009, 5:1-10.
17. Anzai N., Ichida K., Jutabha P., Kimura T., Babu E., Jin C.J., et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 2008, 283:26834-26838.
18. Woodward O.M., Köttgen A., Coresh J., Boerwinkle E., Guggino W.B., Köttgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 2009, 106:10338-10342.
19. Reimer R.J., Edwards R.H. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pflugers Arch 2004, 447:629-635.
20. Jutabha P., Anzai N., Kitamura K., Taniguchi A., Kaneko S., Yan K., et al. Human sodium-phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem 2010, 285:35123-35132.
21. Shibui A., Tsunoda T., Seki N., Suzuki Y., Sugane K., Sugano S. Isolation and chromosomal mapping of a novel human gene showing homology to Na+/PO4 cotransporter. J Hum Genet 1999, 44:190-192.
22. Ekaratanawong S., Anzai N., Jutabha P., Miyazaki H., Noshiro R., Takeda M., et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 2004, 94:297-304.
23. Halestrap A.P., Meredith D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 2004, 447:619-628.
24. Miyazaki H., Anzai N., Ekaratanawong S., Sakata T., Shin H.J., Jutabha P., et al. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol 2005, 16:3498-3506.
25. Hediger M.A., Johnson R.J., Miyazaki H., Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005, 20:125-133.
26. Anzai N., Enomoto A., Endou H. Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep 2005, 7:227-234.
27. Anzai N., Jutabha P., Endou H. Renal solute transporters and their relevance to serum urate disorder. Curr Hypertens Rev 2010, 6:148-154.
28. Anzai N., Jutabha P., Kimura T., Fukutomi T. Urate transport: relationship with serum urate disorder. Curr Rheumatol Rev 2011, 7:123-131.
29. Kahn A.M., Weinman E.J. Urate transport in the proximal tubule: in vivo and vesicle studies. Am J Physiol 1985, 249:F789-F798.
30. Roch-Ramel F., Guisan B. Renal transport of urate in humans. News Physiol Sci 1999, 14:80-84.
31. Shin H.J., Takeda M., Enomoto A., Fujimura M., Miyazaki H., Anzai N., et al. Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology (Carlton) 2011, 16:156-162.
32. Ichida K., Hosoyamada M., Hisatome I., Enomoto A., Hikita M., Endou H., et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004, 15:164-173.
33. Hagos Y., Stein D., Ugele B., Burckhardt G., Bahn A. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 2007, 18:430-439.
34. Bahn A., Hagos Y., Reuter S., Balen D., Brzica H., Krick W., et al. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 2008, 283:16332-16341.
35. Augustin R., Carayannopoulos M.O., Dowd L.O., Phay J.E., Moley J.F., Moley K.H. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 2004, 279:16229-16236.
36. Anzai N., Jutabha P., Kaneko S., Sakamoto Y., Endou H., Sakurai H. Voltage-dependent urate transport on a urate efflux transporter URATv1 expressed in Xenopus oocytes [abstract]. J Pharmacol Sci 2010, 112:202P.
37. Bibert S., Hess S.K., Firsov D., Thorens B., Geering K., Horisberger J.D., et al. Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol 2009, 297:F612-F619.
38. Dinour D., Gray N.K., Campbell S., Shu X., Sawyer L., Richardson W., et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 2010, 21:64-72.
39. Preitner F., Bonny O., Laverrière A., Rotman S., Firsov D., Da Costa A., et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci U S A 2009, 106:15501-15506.
40. Kimura T., Tsukada A., Amonpatumrat S., Fukutomi T., Jutabha P., Ichida K., et al. Elucidation of urate transport mechanism by analysis of renal urate transporters' transgenic mice [abstract]. J Pharmacol Sci 2010, 112:66P.
41. Ichida K., Hosoyamada M., Kimura H., Takeda M., Utsunomia Y., Hosoya T., et al. Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int 2003, 63:143-155.
42. Eraly S.A., Vallon V., Rieg T., Gangoiti J.A., Wikoff W.R., Siuzdak G., et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 2008, 33:180-192.
43. Bakhiya A., Bahn A., Burckhardt G., Wolff N. Human organic anion transporter 3 (hOAT3)can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem 2003, 13:249-256.
44. Sato M., Mamada H., Anzai N., Shirasaka Y., Nakanishi T., Tamai I. Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human. Biol Pharm Bull 2010, 33:498-503.
45. Uchino H., Tamai I., Yamashita K., Minemoto Y., Sai Y., Yabuuchi H., et al. p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem Biophys Res Commun 2000, 270:254-259.
46. Sato M., Iwanaga T., Mamada H., Ogihara T., Yabuuchi H., Maeda T., et al. Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res 2008, 25:639-646.
47. El-Sheikh A.A., van den Heuvel J.J., Koenderink J.B., Russel F.G. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br J Pharmacol 2008, 155:1066-1075.
48. Urano W., Taniguchi A., Anzai N., Inoue E., Kanai Y., Yamanaka M., et al. Sodium-dependent phosphate cotransporter type 1 (NPT1) sequence polymorphisms in male patients with gout. Ann Rheum Dis 2010, 69:1232-1234.
49. Iharada M., Miyaji T., Fujimoto T., Hiasa M., Anzai N., Omote H., et al. Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl--dependent urate exporter. J Biol Chem 2010, 285:26107-26113.
50. Melis D., Havelaar A.C., Verbeek E., Smit G.P., Benedetti A., Mancini G.M., et al. NPT4, a new microsomal phosphate transporter: mutation analysis in glycogen storage disease type Ic. J Inherit Metab Dis 2004, 27:725-733.
51. Sorensen L.B., Levinson D.J. Origin and extrarenal elimination of uric acid in man. Nephron 1975, 14:7-20.
52. Krishnamurthy P., Schuetz J.D. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 2006, 46:381-410.
53. Ishikawa T., Nakagawa H. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics. J Exp Ther Oncol 2009, 8:5-24.
54. Huls M., Brown C.D., Windass A.S., Sayer R., van den Heuvel J.J., Heemskerk S., et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 2008, 73:220-225.
55. Nakamura M., Anzai N., Jutabha P., Sato H., Sakurai H., Ichida K. Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters. J Pharmacol Sci 2010, 114:115-118.
56. Illig T., Gieger C., Zhai G., Römisch-Margl W., Wang-Sattler R., Prehn C., et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010, 42:137-141.
57. van der Harst P., Bakker S.J., de Boer R.A., Wolffenbuttel B.H., Johnson T., et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet 2010, 19:387-395.
58. Thomson R.B., Wang T., Thomson B.R., Tarrats L., Girardi A., Mentone S., et al. Role of PDZK1 in membrane expression of renal brush border ion exchangers. Proc Natl Acad Sci U S A 2005, 102:13331-13336.
59. Watanabe S., Kang D.H., Feng L., Nakagawa T., Kanellis J., Lan H., et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002, 40:355-360.
60. Wu X., Wakamiya M., Vaishnav S., Geske R., Montgomery C., Jones P., et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A 1994, 91:742-746.